Parallel Advisors’s Elevance Health ELV Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$888K Sell
2,282
-503
-18% -$196K 0.02% 446
2025
Q1
$1.21M Buy
2,785
+328
+13% +$143K 0.03% 349
2024
Q4
$907K Sell
2,457
-1,357
-36% -$501K 0.02% 420
2024
Q3
$1.98M Sell
3,814
-106
-3% -$55.1K 0.05% 248
2024
Q2
$2.12M Buy
3,920
+339
+9% +$184K 0.05% 229
2024
Q1
$1.86M Buy
3,581
+530
+17% +$275K 0.05% 243
2023
Q4
$1.44M Sell
3,051
-98
-3% -$46.2K 0.04% 267
2023
Q3
$1.37M Sell
3,149
-225
-7% -$98K 0.05% 250
2023
Q2
$1.5M Buy
3,374
+265
+9% +$118K 0.05% 246
2023
Q1
$1.43M Sell
3,109
-983
-24% -$452K 0.05% 247
2022
Q4
$2.1M Buy
4,092
+309
+8% +$159K 0.09% 151
2022
Q3
$1.72M Buy
3,783
+850
+29% +$386K 0.08% 164
2022
Q2
$1.42M Sell
2,933
-53
-2% -$25.6K 0.07% 184
2022
Q1
$1.5M Buy
2,986
+238
+9% +$120K 0.06% 209
2021
Q4
$1.27M Buy
2,748
+247
+10% +$115K 0.05% 231
2021
Q3
$933K Buy
2,501
+20
+0.8% +$7.46K 0.04% 267
2021
Q2
$947K Buy
2,481
+31
+1% +$11.8K 0.04% 264
2021
Q1
$880K Sell
2,450
-90
-4% -$32.3K 0.04% 251
2020
Q4
$816K Sell
2,540
-193
-7% -$62K 0.04% 239
2020
Q3
$734K Sell
2,733
-68
-2% -$18.3K 0.05% 234
2020
Q2
$736K Buy
2,801
+48
+2% +$12.6K 0.05% 226
2020
Q1
$624K Sell
2,753
-242
-8% -$54.9K 0.05% 205
2019
Q4
$905K Sell
2,995
-72
-2% -$21.8K 0.07% 195
2019
Q3
$736K Sell
3,067
-329
-10% -$79K 0.06% 208
2019
Q2
$958K Sell
3,396
-46
-1% -$13K 0.09% 157
2019
Q1
$988K Buy
3,442
+259
+8% +$74.3K 0.11% 136
2018
Q4
$836K Buy
3,183
+220
+7% +$57.8K 0.12% 131
2018
Q3
$812K Buy
2,963
+1,137
+62% +$312K 0.1% 154
2018
Q2
$434K Buy
1,826
+61
+3% +$14.5K 0.06% 202
2018
Q1
$388K Sell
1,765
-12
-0.7% -$2.64K 0.06% 207
2017
Q4
$400K Sell
1,777
-2
-0.1% -$450 0.07% 196
2017
Q3
$389K Sell
1,779
-67
-4% -$14.7K 0.07% 199
2017
Q2
$344K Buy
1,846
+28
+2% +$5.22K 0.06% 224
2017
Q1
$327K Buy
1,818
+352
+24% +$63.3K 0.07% 210
2016
Q4
$211K Buy
+1,466
New +$211K 0.05% 249